Meeder Asset Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-174
| Closed | -$121K | – | 1903 |
|
|
2020
Q3 | $121K | Buy |
174
+51
| +41% | +$35.5K | 0.01% | 731 |
|
|
2020
Q2 | $104K | Buy |
123
+96
| +356% | +$81.2K | 0.01% | 755 |
|
|
2020
Q1 | $8K | Buy |
27
+24
| +800% | +$7.11K | ﹤0.01% | 1604 |
|
|
2019
Q4 | $1K | Sell |
3
-47
| -94% | -$15.7K | ﹤0.01% | 2115 |
|
|
2019
Q3 | $5K | Buy |
+50
| New | +$5K | ﹤0.01% | 1747 |
|